Literature DB >> 19419298

Vps33a mediates RANKL storage in secretory lysosomes in osteoblastic cells.

Yoshiaki Kariya1, Masashi Honma, Shigeki Aoki, Atsushi Chiba, Hiroshi Suzuki.   

Abstract

Previous studies have indicated that the amount of RANKL expressed on the cell surface of osteoblasts or bone marrow stromal cells (BMSCs) is considered an important factor determining the extent of osteoclast activation. However, subcellular trafficking of RANKL and its regulatory mechanisms in osteoblastic cells is still unclear. In this study, we showed that RANKL is predominantly localized in lysosomal organelles, but little is found on the cell surface of osteoblastic cells. We also showed that RANKL is relocated to the plasma membrane in response to stimulation with RANK-Fc-coated beads, indicating that the lysosomal organelles where RANKL is localized function as secretory lysosomes. In addition, using a protein pull-down method, we identified vacuolar protein sorting (Vps)33a as interacting with the cytoplasmic tail of RANKL. Furthermore, knockdown of Vps33a expression reduced the lysosomal storage of RANKL and caused the accumulation of newly synthesized RANKL in the Golgi apparatus, indicating that Vps33a is involved in transporting RANKL from the Golgi apparatus to secretory lysosomes. We also showed that suppression of Vps33a affects the cell surface expression level of RANKL and disrupts the regulated behavior of RANKL. These results suggest that RANKL storage in secretory lysosomes is important to control osteoclast activation and to maintain bone homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419298     DOI: 10.1359/jbmr.090409

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms.

Authors:  Anthony Martin; Jiali Yu; Jian Xiong; Aysha B Khalid; Benita Katzenellenbogen; Sung Hoon Kim; John A Katzenellenbogen; Suchinda Malaivijitnond; Yankel Gabet; Susan A Krum; Baruch Frenkel
Journal:  J Cell Physiol       Date:  2017-05-11       Impact factor: 6.384

Review 2.  Mechanisms of RANKL delivery to the osteoclast precursor cell surface.

Authors:  Masashi Honma; Yuki Ikebuchi; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2020-10-12       Impact factor: 2.626

3.  Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.

Authors:  Anthony Martin; Jian Xiong; Theodora Koromila; Jie S Ji; Stephanie Chang; Yae S Song; Jonathan L Miller; Chun-Ya Han; Paul Kostenuik; Susan A Krum; Nyam-Osor Chimge; Yankel Gabet; Baruch Frenkel
Journal:  Bone       Date:  2015-02-17       Impact factor: 4.398

Review 4.  Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases.

Authors:  Haibo Zhao
Journal:  Traffic       Date:  2012-07-24       Impact factor: 6.215

Review 5.  Regulatory mechanisms of RANKL presentation to osteoclast precursors.

Authors:  Masashi Honma; Yuki Ikebuchi; Yoshiaki Kariya; Hiroshi Suzuki
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

6.  The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.

Authors:  Genki Kato; Yasuhiro Shimizu; Yuki Arai; Natsuki Suzuki; Yasutaka Sugamori; Miki Maeda; Mariko Takahashi; Yukihiko Tamura; Noriyuki Wakabayashi; Ramachandran Murali; Takashi Ono; Keiichi Ohya; Setsuko Mise-Omata; Kazuhiro Aoki
Journal:  Arthritis Res Ther       Date:  2015-09-12       Impact factor: 5.156

Review 7.  The Effects of Receptor Activator of NF-κB Ligand-Binding Peptides on Bone Resorption and Bone Formation.

Authors:  Fatma Rashed; Shingo Kamijyo; Yuri Shimizu; Yuna Hirohashi; Masud Khan; Yasutaka Sugamori; Ramachandran Murali; Kazuhiro Aoki
Journal:  Front Cell Dev Biol       Date:  2021-07-06

8.  Comparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation.

Authors:  Ying Peng; Lili Deng; Yuedi Ding; Quancheng Chen; Yu Wu; Meilin Yang; Yaping Wang; Qiang Fu
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

9.  Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.

Authors:  L B Solberg; E Stang; S-H Brorson; G Andersson; F P Reinholt
Journal:  Histochem Cell Biol       Date:  2014-09-09       Impact factor: 4.304

10.  Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling.

Authors:  Yasutaka Sugamori; Setsuko Mise-Omata; Chizuko Maeda; Shigeki Aoki; Yasuhiko Tabata; Ramachandran Murali; Hisataka Yasuda; Nobuyuki Udagawa; Hiroshi Suzuki; Masashi Honma; Kazuhiro Aoki
Journal:  Bioessays       Date:  2016-06-27       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.